Skip to content

Bruker BRKR Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
Revvity logo
RevvityRVTY
Lantheus Holdings logo
Lantheus HoldingsLNTH
IDEX logo
IDEXIEX

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's common stock, shares issued (in shares)?
Bruker (BRKR) reported common stock, shares issued (in shares) of $183.13M in Q1 2026.
How has Bruker's common stock, shares issued (in shares) changed year-over-year?
Bruker's common stock, shares issued (in shares) increased by 0.3% year-over-year, from $182.5M to $183.13M.
What is the long-term trend for Bruker's common stock, shares issued (in shares)?
Over 4 years (2020 to 2024), Bruker's common stock, shares issued (in shares) has grown at a 1.2% compound annual growth rate (CAGR), from $174.05M to $182.46M.